• About us
    • About ImaBiotech
    • Missions, visions and values
    • Our team
    • Quality Engagement
    • Careers
    • Investors
    • Media relation
    • Contact Imabiotech
  • Innovative platforms
    • Molecular Imaging
    • Elemental Imaging
    • Laser Microdissection
    • Multimaging™
    • Quantinetix™
    • 2,500 biomarkers assays
  • Therapeutic areas
    • Oncology
    • Dermatology
    • Ophthalmology
    • Respiratory diseases
    • Central Nervous System
    • Metabolic Disorders
  • Services
    • Structure Elucidation
    • Biomarkers Discovery
    • Formulation Screening
    • Skin Permeability
    • Drug Delivery
    • In vivo Proof of Concept
    • Whole Body PK
    • PK/PD-Pharmacology
    • Target Exposure
    • Safety support
    • Translational biomarkers
    • Clinical Drug Efficacy
  • Ressources
    • Conferences and Webinars
    • Articles and research
    • Press releases & In the Press
    • Imabiotech news
Votre navigateur ne semble pas compatible pour la lecture de cette vidéo. Veuillez mettre à jour votre navigateur.

For Better Drug Development

We offer innovative services for a better drug development

Early Whole Body PK

Immuno-Oncology

Dermatology

Central Nervous System

Discover our technologies: Quantitative Mass Spectrometry Imaging, Cloud, Big Data, Machine Learning...

Ophthalmology

Contact us

© ImaBiotech 2018-2019